WO2020119104A1 - Procédé, dispositif et appareil de surveillance et de gestion de médicaments pour des institutions médicales et support d'informations - Google Patents

Procédé, dispositif et appareil de surveillance et de gestion de médicaments pour des institutions médicales et support d'informations Download PDF

Info

Publication number
WO2020119104A1
WO2020119104A1 PCT/CN2019/095409 CN2019095409W WO2020119104A1 WO 2020119104 A1 WO2020119104 A1 WO 2020119104A1 CN 2019095409 W CN2019095409 W CN 2019095409W WO 2020119104 A1 WO2020119104 A1 WO 2020119104A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug
medical institution
information
import
medicine
Prior art date
Application number
PCT/CN2019/095409
Other languages
English (en)
Chinese (zh)
Inventor
李云峰
Original Assignee
平安医疗健康管理股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 平安医疗健康管理股份有限公司 filed Critical 平安医疗健康管理股份有限公司
Publication of WO2020119104A1 publication Critical patent/WO2020119104A1/fr

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers

Definitions

  • This application relates to the field of medical technology, and in particular, to methods, devices, equipment, and storage media for drug monitoring and management in medical institutions.
  • the main purpose of this application is to provide a drug monitoring and management method, device, equipment and storage medium for medical institutions, aiming to achieve effective monitoring and management of drugs based on the analysis of the purchase and sale data of medical institutions.
  • the present application provides a drug monitoring and management method for a medical institution, which includes the following steps:
  • the drug sales information of the medical institution is obtained, and a substantial review of the medical institution is conducted based on the drug sales information;
  • the present application also provides a drug monitoring and management device for a medical institution, the drug monitoring and management device for the medical institution includes:
  • the receiving module is used to receive the drug management review request and determine the medical institution to be reviewed;
  • the primary review module is used to obtain the drug import information of the medical institution and conduct a primary review of the medical institution based on the drug import information;
  • the substantive examination module is used to obtain the drug sales information of the medical institution if the primary examination of the medical institution passes, and perform a substantive examination of the medical institution based on the drug sales information;
  • the sending prompt module is used to send prompt information to the preset drug monitoring and management platform if the medical institution fails the substantial examination.
  • this application also provides a medical monitoring and management device for medical institutions
  • the medicine monitoring and management device of the medical institution includes: a memory, a processor, and computer-readable instructions stored on the memory and operable on the processor, wherein:
  • this application also provides a computer storage medium
  • Computer-readable instructions are stored on the computer storage medium. When the computer-readable instructions are executed by the processor, the steps of the medical monitoring and management method of the medical institution described above are implemented.
  • FIG. 1 is a schematic structural diagram of a device for a hardware operating environment involved in an embodiment of the present application
  • FIG. 2 is a schematic flowchart of a first embodiment of a drug monitoring and management method of a medical institution applying for this;
  • FIG. 3 is a schematic diagram of functional modules of an embodiment of a drug monitoring and management device of a medical institution of the application.
  • the server receives the drug management review request and determines the medical institution to be reviewed; to obtain the drug import information of the medical institution, according to The drug import information conducts a preliminary review of the medical institution; if the medical institution passes the primary review, the drug sales information of the medical institution is obtained, and the medical institution is substantially reviewed based on the drug sales information; If the substantive examination of the medical institution fails, it sends a prompt message to the preset drug monitoring and management platform. That is, the server supervises and inspects the purchase and sale of medicines in medical institutions, and investigates the flow direction and timely disposal of abnormal purchases and sales and large transactions. In this application, the monitoring of the purchase and sale of medicines in medical institutions is implemented to achieve effective monitoring and management of medicines.
  • the drug import information conducts a preliminary review of the medical institution; if the medical institution passes the primary review, the drug sales information of the medical institution is obtained, and the medical institution is substantially reviewed based on the drug sales information; If the substantive examination of the medical institution fails, it sends a prompt message to the preset drug monitoring and management platform
  • FIG. 1 is a server of a hardware operating environment involved in an embodiment of the present application (also called a drug monitoring and management device of a medical institution, where the drug monitoring and management device of a medical institution may be a drug of a separate medical institution
  • the structure of the monitoring and management device may also be formed by combining other devices with the drug monitoring and management device of the medical institution).
  • the server in the embodiment of the present application refers to a computer that manages resources and provides services to users, and is generally divided into a file server, a database server, and an application-readable instruction server.
  • a computer or computer system running the above software is also called a server.
  • the server may include a processor 1001, such as a central processor (Central Processing Unit, CPU), network interface 1004, user interface 1003, memory 1005, communication bus 1002, chipset, disk system, network and other hardware.
  • the communication bus 1002 is used to implement connection communication between these components.
  • the user interface 1003 may include a display (Display), an input unit such as a keyboard (Keyboard), and the optional user interface 1003 may also include a standard wired interface and a wireless interface.
  • the network interface 1004 may optionally include a standard wired interface and a wireless interface (such as wireless fidelity WIreless-FIdelity, WIFI interface).
  • the memory 1005 may be a high-speed random access memory (random access memory, RAM), can also be a stable memory (non-volatile memory), such as disk storage.
  • the memory 1005 may optionally be a storage device independent of the foregoing processor 1001.
  • the computer software product is stored in a storage medium (storage medium: also called computer storage medium, computer medium, readable medium, readable storage medium, computer readable storage medium, or directly called medium, etc., which can be
  • the non-volatile readable storage medium such as RAM, magnetic disk, and optical disk, includes several instructions to enable a terminal device (which may be a mobile phone, computer, server, air conditioner, or network device, etc.) to execute each
  • the memory 1005 as a computer storage medium may include an operating system, a network communication module, a user interface module, and computer-readable instructions.
  • the network interface 1004 is mainly used to connect to a back-end database and perform data communication with the back-end database;
  • the user interface 1003 is mainly used to connect to a client (client, also called a user terminal or terminal, an embodiment of the present application
  • client also called a user terminal or terminal, an embodiment of the present application
  • the terminal may be a fixed terminal or a mobile terminal), and performs data communication with the client;
  • the processor 1001 may be used to call computer-readable instructions stored in the memory 1005 and perform drug monitoring of medical institutions provided by the following embodiments of the present application Steps in management methods.
  • the drug monitoring and management method of the medical institution includes:
  • Step S10 Receive a drug management review request and determine the medical institution to be reviewed.
  • the drug management reviewer triggers the drug management review request on the terminal, where the method and form of triggering the drug management review request are not limited, for example, it can be triggered manually by the drug management reviewer, or by voice;
  • the terminal receives the drug management review request and sends To the server, the server receives the drug management review request sent by the terminal.
  • the server obtains the identification information of the medical institution contained in the request for medical management review (the identification information of the medical institution refers to the name of the medical institution, or the pre-set medical institution number information).
  • Identify the medical institution identification information to determine the medical institution to be reviewed (medical institution can refer to a hospital or a pharmacy; in this application, the medical institution can be understood as a drug intermediary, the upstream channel of the medical institution refers to the drug manufacturer, the downstream of the medical institution Channel refers to the patient), so that the server can review the drugs in the medical institution to be reviewed; in this embodiment, the drug review is conducted around the purchase and sale channels of the drug, that is, whether the drug purchased by the medical institution is a fake drug is reviewed. Whether the sales of medicines in medical institutions meet the regulations.
  • the drug management review request is triggered for the drug of the medical institution.
  • the drug management reviewer triggers the drug management review request for the medical institution A on the terminal.
  • the terminal receives the drug management review request and reviews the drug management review.
  • the request is sent to the server, and the server receives the drug management review request, and takes the medical institution A as the medical institution to be reviewed to review the drugs corresponding to the medical institution A.
  • Step S20 Obtain the drug import information of the medical institution, and conduct a preliminary review of the medical institution based on the drug import information.
  • the server After the server receives the drug management review request, the server needs to conduct a primary review of the medical institution.
  • the so-called primary review is to review the source of the drug in the medical institution, that is, the server obtains the drug import information in the medical institution.
  • the drug import The information includes: invoices, accounts and certificates for drug imports, etc. It should be noted that the invoices, accounts and certificates for drug imports contain the drug identification information, drug quantity information, drug channel source information, drug price information for imported drugs and many more.
  • the server After obtaining the medicine import information, the server conducts a preliminary review of the medical institution based on the medicine import information, specifically:
  • the server obtains the certificate (license, for example, "drug production license” and “drug business license” in the import channel), ticket (invoice, accompanying paper), account (physical account, financial account), For goods (physical medicines) and payment (payments), the server determines whether the medicines in the medical institution correspond to the medicines in the import information based on the acquired medicine import information.
  • the certificate license, for example, "drug production license” and “drug business license” in the import channel
  • ticket invoice, accompanying paper
  • account physical account, financial account
  • payment payments
  • the server judges whether the drug manufacturer (also called the upstream channel) of the imported drug in the medical institution has certificates such as "Drug Production License” and "Drug Business License” to determine whether the drug manufacturer meets the specifications.
  • the server compare invoices, notes accompanying the goods), accounts (physical accounts, financial accounts), goods (physical medicines), and payment (payments), conduct a preliminary review of the medical institution, specifically, the server judges whether the medical institution has physical medicines and If the medical book information does not match, if there is a mismatch between the physical medicine and the medical book information in the medical institution, the primary review of the medical institution will not pass; if there is no mismatch between the physical medicine and the drug book information in the medical institution, then Passed the preliminary examination of the medical
  • the monitoring of the drug import channel is realized, which effectively avoids the situation of the medical institution importing fake and inferior drugs, guarantees the quality of the drug in the medical institution, and effectively prevents The problem of unclear sources of imported medicines in medical institutions.
  • step S30 if the medical institution passes the preliminary examination, the medical sales information of the medical institution is obtained, and the medical institution is substantively reviewed based on the medical sales information.
  • the server obtains the drug sales information of the medical institution, where the drug sales information includes: drug sales time, drug type information, drug quantity information, drug seller information (doctor information) , Drug purchaser information (patient information), etc., the server analyzes the drug sales information to achieve a substantial review of the medical institution.
  • the server determines the sales drug corresponding to the drug sales information, queries the preset drug dosage table, and obtains the standard dosage of each of the sales drugs; the server compares the sales volume of each drug sold in the drug sales information with the respective Compare the standard dosage to determine whether there is a sales drug that does not match the standard dosage. If there is a sales drug that does not match the standard dosage, the medical institution will not pass the substantive review; if there is no If the standard drug dosage does not match the sale of the drug, the medical institution will substantially review it.
  • the server obtains the target doctor to be reviewed in the drug sales information, obtains the prescription form associated with the target doctor and the prescription authority of the target doctor; analyzes each of the prescription forms, and obtains each of the prescription forms Prescription drugs in the prescription; compare the drug authority of each of the prescription drugs with the prescription authority to determine whether there is a prescription drug that does not match the prescription authority; if there is a prescription drug that does not match the prescription authority, then The substantive examination of the medical institution fails; if there is no prescription drug that does not conform to the prescription authority, the substantive examination of the medical institution passes.
  • the analysis and review of the drug sales information in the medical institution is given to avoid the situation of drug abuse, so as to finally realize the drug monitoring management based on the medical institution.
  • Step S40 If the medical institution fails to pass the substantive examination, it sends a prompt message to the preset drug monitoring and management platform.
  • the server determines that the substantive examination of the medical institution fails, that is, the server determines that there is an unreasonable drug sales situation in the medical institution, the server sends a prompt message to the preset drug monitoring and management platform.
  • the preset drug monitoring and management platform refers to the preset The drug monitoring and management platform, for example, the system of the Food and Drug Administration, specifically, includes:
  • Step a if the medical institution does not pass the substantive examination, obtain the drug import information and the drug sales information;
  • Step b The server edits the drug import information and the drug sales information to form prompt information, and the server sends the prompt information to a preset drug monitoring and management platform.
  • the monitoring of the drug import channel is realized, which effectively avoids the import of fake and inferior drugs by the medical institution, and ensures the quality of the drug in the medical institution. Further, Through the analysis and review of drug sales information in medical institutions, to avoid drug abuse, in order to ultimately achieve drug monitoring and management based on medical institutions.
  • This embodiment is a refinement of step S20 in the first embodiment.
  • This embodiment provides a specific implementation manner in which the server conducts a preliminary review of the medical institution based on the drug import information. Methods include:
  • Step S21 Obtain the medicine import information of the medical institution, and determine the imported medicine corresponding to the medicine import information.
  • the server obtains the medicine import information of the medical institution.
  • the medicine import information includes: medicine import invoices, accounts and certificates, etc. It should be noted that the medicine import invoices, accounts and certificates contain the medicine identification information of the imported medicines , Medicine quantity information, medicine channel source information, medicine price information, etc., the server obtains the medicine import information in the medical institution by obtaining the invoice details of each invoice, and after obtaining the medicine import information, the server obtains the medicine identification in the medicine import information , The server determines imported medicines based on the medicine identification.
  • Step S22 query the preset medicine management database to obtain the import channel information of each imported medicine
  • the server queries the preset medicine management database (the preset medicine management database refers to the preset medicine information database), and the server obtains the import channel information of each imported medicine from the preset medicine management database, that is, the server obtains the medicine of each imported medicine ID, the server obtains the import channel information corresponding to the drug ID in the preset drug management database.
  • the preset medicine management database refers to the preset medicine information database
  • the import channel information includes: the qualification certification documents and import bills of each import channel
  • the qualification certification documents include: “Drug Production License”, “Drug Business License”, “Business License”, “Drug Business Quality Specification” ( (GSP certificate), “Tax Registration Certificate”, “Organization Code Certificate”, “Hygiene License”, etc.
  • import bills include: tickets (invoices, accompanying papers), accounts (physical accounts, financial accounts), goods ( Medicine in kind), payment (payment), etc.
  • step S23 it is determined whether the qualification certification documents of each import channel are complete.
  • the server judges whether the qualification certification documents of each import channel are complete, that is, there are many types of medicines imported by medical institutions in this embodiment, and different imported medicines may come from different import channels.
  • each kind of The import determination corresponding to the drug is reviewed. Specifically, the server obtains the qualification certification documents of each import channel, compares the qualification certification documents of each import channel with the preset types of qualification certification documents, and determines the Whether the qualification certificate is complete.
  • the medical institution interface purchases medicine a from the import channel A
  • the server buys the medicine b from the import channel B
  • the server obtains the qualification certification documents of the import channel A
  • the server judges whether the qualification certification documents of the import channel A and the import channel B are complete.
  • Step S24 if the qualification certification documents are complete, compare the invoice details in each of the import bills with the drug import information to determine whether there are imported drugs that do not match the invoice details;
  • the server compares the invoice details in each import bill with the drug import information, that is, the server in this embodiment compares the invoice details of import channel A with The drug import information in the medical institution is compared to determine whether there are imported drugs in the medical institution that do not match the invoice details.
  • step S25 if there is an imported medicine that does not match the invoice details, the primary review of the medical institution fails. If there is no imported medicine that does not match the invoice details, the medical institution passes the preliminary examination.
  • the server determines that there is an imported drug in the medical institution that does not match the invoice details, that is, the server determines that the medical institution has a source of counterfeit drug purchases, falsifies the drug sales flow, and conceals the actual drug purchase and sales records, bills, vouchers, data, etc.
  • the server determines that the medical institution has a suspicion of deliberately causing the traceability of business operations, and the server determines that the primary examination of the medical institution fails.
  • the server determines that the purchase and sales records of the medical institution are complete and true; then the server passes the primary review of the medical institution. Further, if the primary review of the medical institution passes, Then, the server also needs to acquire the drug sales information of the medical institution, and conduct a substantial review of the medical institution based on the drug sales information, which will be described in detail in the following embodiments.
  • This embodiment is a refinement of step S30 in the first embodiment.
  • Monitoring and management methods include:
  • Step S31 Determine the sales drugs corresponding to the sales information of the drugs, query the preset dosage table of drugs, and obtain the standard dosage of each of the sales drugs.
  • the server determines the sales drug corresponding to the drug sales information, that is, the server determines the sold drug according to the sold drug identification information in the sales information, and further, the server queries the preset drug dosage table (the preset drug dosage table refers to a preset The standard information table of the dosage of each medicine), the server obtains the standard dosage of each of the sold medicines from the preset medicine dosage table.
  • the preset drug dosage table refers to a preset The standard information table of the dosage of each medicine
  • Step S32 Compare the sales amount of each drug sold in the drug sales information with the respective standard dosage of medicine, and determine whether there is a sales drug that does not match the standard dosage of medicine.
  • the server compares the drug sales dose of each sold drug in the drug sales information with the respective standard drug dose, that is, usually, the drug dose purchased by the patient is similar to the standard drug dose, then the server sells the drug by selling the drug
  • the dosage is compared with the standard dosage of the medicine, and according to the comparison result, it is judged whether there is a phenomenon of wholesale medicine.
  • Step S33 if there is a sales drug that does not match the standard medication dose, the medical institution fails the substantial review; if there is no sales drug that does not match the standard medication dose, the medical institution passes the substantial review .
  • the server determines that there is a sales drug that does not match the standard drug dosage, that is, there is an abnormality in the medical sales dose in the medical institution (the abnormal situation refers to the phenomenon of wholesale drug reselling)
  • the server determines that the medical institution does not substantially review Pass; if there is no sales of drugs that do not match the standard dosage, that is, the sales volume of each drug in the medical institution meets the specifications, then the medical institution substantially passes the review.
  • the sales volume of medicines is monitored to prevent medical institutions from reselling large quantities of medicines, and to avoid the abuse of medicines.
  • This embodiment is a refinement of step S30 in the first embodiment.
  • This embodiment provides another specific implementation manner in which the server performs a substantial review of the medical institution based on the drug sales information.
  • Drug monitoring and management methods include:
  • Step S34 Obtain the target doctor to be reviewed in the drug sales information, obtain the prescription form associated with the target doctor and the prescription authority of the target doctor.
  • the server obtains the target doctor to be reviewed in the medicine sales information, that is, in this embodiment, the server obtains the doctor identification in the medicine sales information.
  • the medicine sales information obtained by the server is a doctor’s name on a prescription form
  • the server obtains The name of the doctor on the prescription form, and using the doctor corresponding to the name as the target doctor, the server obtains the prescription form associated with the target doctor and the prescription authority of the target doctor, that is, the server obtains all the prescription forms issued by the target doctor
  • the server obtains
  • the target doctor's prescription authority prescription authority refers to the target doctor's authority to prescribe medicine, that is, some medicines are strictly controlled and only certain doctors can prescribe).
  • Step S35 Analyze each of the prescriptions and obtain the prescription drugs in each of the prescriptions.
  • the server analyzes each of the prescriptions, that is, the server recognizes the text information in each prescription through the preset OCR recognition technology, where OCR (Optical Character Recognition (optical character recognition) refers to the process in which electronic devices (such as scanners or digital cameras) check characters printed on paper, determine their shape by detecting dark and bright patterns, and then use character recognition to translate the shape into computer text; After the server obtains the text information in the prescription, the server obtains the prescription drugs in each prescription.
  • OCR Optical Character Recognition
  • step S36 the medicine authority of each prescription medicine is compared with the prescription authority to determine whether there is a prescription medicine that does not match the prescription authority.
  • the server obtains the medicine authority of each prescription medicine (the medicine authority refers to the medicine sales authority), the server compares the medicine authority of each prescription medicine with the prescription authority, and judges whether there is the prescription authority Inconsistent prescription drugs.
  • Step S37 if there is a prescription drug that does not match the prescription authority, the medical institution fails the substantive review; if there is no prescription drug that does not match the prescription authority, the medical institution has the substantive review.
  • the server determines that the medical institution does not pass the substantive examination; if there is no prescription drug that does not match the prescription authority That is, if the target doctor does not issue prescription drugs beyond the authority, the medical institution substantially passes the examination.
  • the doctors in the medical institution are reviewed, which effectively avoids the phenomenon that the doctor exceeds the authority to prescribe drugs, regulates the drug sales channels in the medical institution, and realizes the scientific management and monitoring of drugs.
  • the server can rate the medical institution, specifically:
  • Step S50 If the medical institution passes the substantive examination, then obtain the doctor information, drug information, and patient information contained in the medical institution.
  • the server can also rate the medical institution, that is, the server obtains the doctor information contained in the medical institution (the doctor information includes: the total number of doctors, the titles of each doctor, etc.), Drug information (drug information includes: types of drugs, manufacturers of drugs, etc.) and patient information (patient information includes types of patients, number of patients, patient evaluation information, etc.).
  • the doctor information includes: the total number of doctors, the titles of each doctor, etc.
  • Drug information includes: types of drugs, manufacturers of drugs, etc.
  • patient information patient information includes types of patients, number of patients, patient evaluation information, etc.
  • step S60 the medical institution is rated according to the doctor information, the drug information and the patient information to obtain the grade of the medical institution.
  • the server ranks the medical institution according to the doctor information, the medicine information, and the patient information. For example, the server determines that the medical institution has a total of 50 doctors, 5 A-level doctors, and 30 B-level doctors. There are 15 doctors with C-level titles. The medical institutions have a complete range of medicines and many patients. The patient evaluation information is good, and the medical institution has a rating of B.
  • the server ranks the medical institution according to the doctor information, the drug information, and the patient information, and obtains the medical institution's level, so that the medical institution can reversely optimize the drug's Monitoring and management.
  • the server grants exemption authority to some medical institutions according to the level of the medical institution, while ensuring the quality of drug monitoring and management, and reducing the amount of server data processing, specifically:
  • Step S70 Obtain the level of the medical institution, and compare the level of the medical institution with a preset level.
  • the server obtains the level of the medical institution, and the server compares the level of the medical institution with a preset level, where the preset level refers to a pre-set threshold value of the medical institution's level of exemption, and the preset level can be set according to specific scenarios For example, set to level 3, and the server determines whether to grant the medical institution exemption authority based on the comparison result of the level of the medical institution and the preset level.
  • Step S80 if the level of the medical institution exceeds a preset level, the medical institution is granted exemption authority;
  • the server determines that if the level of the medical institution exceeds the preset level, that is, after the server has reviewed the medical institution and determines that the medical institution purchases and sells drugs reasonably, the server grants the medical institution an exemption authority; if the level of the medical institution If it does not exceed the preset level, upon receiving the drug management review request, the step of acquiring the drug import information of the medical institution and conducting a preliminary review of the medical institution based on the drug import information is performed.
  • the server exempts some excellent medical institutions from internship, reduces the data processing volume of the server, and ensures the strictness of drug monitoring.
  • an embodiment of the present application also proposes a drug monitoring and management device for a medical institution, the drug monitoring and management device for the medical institution includes:
  • the receiving module 10 is used to receive the drug management review request and determine the medical institution to be reviewed;
  • the primary review module 20 is used to obtain the drug import information of the medical institution and perform a primary review on the medical institution based on the drug import information;
  • the substantive examination module 30 is used to obtain the medical sales information of the medical institution if the primary examination of the medical institution passes, and perform a substantive examination of the medical institution according to the medical sale information;
  • the sending prompt module 40 is used to send prompt information to the preset drug monitoring and management platform if the medical institution fails to pass the substantive examination.
  • the primary review module 20 includes:
  • An obtaining unit configured to obtain the medicine import information of the medical institution and determine the imported medicine corresponding to the medicine import information
  • the query unit is used to query a preset drug management database to obtain the import channel information of each of the imported drugs, wherein the import channel information includes: qualification certification documents and import bills of each import channel;
  • the first judgment unit is used to judge whether the qualification certification documents of each import channel are complete
  • the second judgment unit is used to compare the invoice details in each import bill with the drug import information to determine whether there are imported drugs that do not match the invoice details if the qualification certification documents are complete; If there are imported drugs that do not match the invoice details, the primary review of the medical institution fails; if there are no imported drugs that do not match the invoice details, the primary review of the medical institution passes.
  • the substance review module 30 includes:
  • the query unit is used to determine the sales drugs corresponding to the drug sales information, query the preset drug dosage table, and obtain the standard dosage of each of the sales drugs;
  • the comparison unit is used to compare the sales volume of each drug sold in the drug sales information with the respective standard dosage, and determine whether there is a sales drug that does not match the standard dosage.
  • the substance review module 30 includes:
  • An obtaining module configured to obtain a target doctor to be reviewed in the drug sales information, obtain a prescription list associated with the target doctor and the prescription authority of the target doctor;
  • An analysis obtaining unit configured to analyze each of the prescription forms and obtain prescription drugs in each of the prescription forms
  • the comparison output unit is used to compare the medicine authority of each prescription medicine with the prescription authority to determine whether there is a prescription medicine that does not match the prescription authority; if there is a prescription medicine that does not match the prescription authority, Then the substantive examination of the medical institution fails; if there is no prescription drug that does not conform to the prescription authority, the substantive examination of the medical institution passes.
  • the sending prompt module 40 includes:
  • An obtaining unit configured to obtain the medicine import information and the medicine sales information if the medical institution fails the substantive examination
  • a sending prompt unit is used to edit the drug import information and the drug sales information to form prompt information, and send the prompt information to a preset drug monitoring and management platform.
  • the drug monitoring and management device of the medical institution includes:
  • the related information acquisition module is used to acquire doctor information, medicine information and patient information contained in the medical institution if the medical institution substantially passes the examination.
  • the institution evaluation module is used for rating the medical institution according to the doctor information, the drug information and the patient information, to obtain the level of the medical institution.
  • the drug monitoring and management device of the medical institution further includes:
  • a level comparison module used to obtain the level of the medical institution, and compare the level of the medical institution with a preset level
  • a comparative authorization module which is used to grant the examination-free authority to the medical institution if the level of the medical institution exceeds a preset level
  • the acquisition of the drug import information of the medical institution is performed, and the medical institution is subjected to a preliminary review based on the drug import information A step of.
  • the embodiments of the present application also provide a computer storage medium, and the computer storage medium may be a non-volatile storage medium.
  • Computer-readable instructions are stored on the computer storage medium, and when the computer-readable instructions are executed by the processor, the operations in the drug monitoring and management method of the medical institution provided in the foregoing embodiments are implemented.
  • the methods in the above embodiments can be implemented by means of software plus a necessary general hardware platform, and of course, can also be implemented by hardware, but in many cases the former is better Implementation.
  • the technical solution of the present application can be embodied in the form of a software product in essence or part that contributes to the existing technology, and the computer software product is stored in a storage medium (such as ROM/RAM as described above) , Magnetic disk, optical disk), including several instructions to enable a terminal device (which may be a mobile phone, computer, server, network device, etc.) to perform the method described in each embodiment of the present application.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

L'invention concerne un procédé de surveillance et de gestion de médicaments pour des institutions médicales fondé sur une analyse de mégadonnées, comprenant les étapes consistant : à recevoir une demande d'examen de gestion de médicaments et à déterminer une institution médicale à examiner (S10) ; à obtenir des informations relatives à l'importation de médicaments de l'institution médicale et à effectuer un examen préliminaire sur l'institution médicale, selon les informations relatives à l'importation de médicaments (S20) ; si l'institution médicale réussit l'examen préliminaire, à obtenir des informations relatives à la vente de médicaments de l'institution médicale et à effectuer un examen important sur l'institution médicale selon les informations relatives à la vente de médicaments (S30) ; et si l'institution médicale ne réussit pas l'examen important, à envoyer un message d'invite à une plateforme préétablie de surveillance et de gestion de médicaments (S40). Selon le dispositif et l'appareil de surveillance et de gestion de médicaments pour des institutions médicales et un support d'informations, les informations relatives à l'importation de médicaments d'une institution médicale sont analysées et vérifiées pour empêcher que des médicaments de contrefaçon et de mauvaise qualité n'entrent sur le marché ; les informations relatives à la vente de médicaments de l'institution médicale sont analysées et vérifiées pour empêcher tout abus relatif aux médicaments, ce qui met finalement en œuvre la surveillance et la gestion de médicaments d'institutions médicales.
PCT/CN2019/095409 2018-12-13 2019-07-10 Procédé, dispositif et appareil de surveillance et de gestion de médicaments pour des institutions médicales et support d'informations WO2020119104A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811529287.1A CN109616177A (zh) 2018-12-13 2018-12-13 医疗机构的药品监控管理方法、装置、设备和存储介质
CN201811529287.1 2018-12-13

Publications (1)

Publication Number Publication Date
WO2020119104A1 true WO2020119104A1 (fr) 2020-06-18

Family

ID=66007452

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/095409 WO2020119104A1 (fr) 2018-12-13 2019-07-10 Procédé, dispositif et appareil de surveillance et de gestion de médicaments pour des institutions médicales et support d'informations

Country Status (2)

Country Link
CN (1) CN109616177A (fr)
WO (1) WO2020119104A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109616177A (zh) * 2018-12-13 2019-04-12 平安医疗健康管理股份有限公司 医疗机构的药品监控管理方法、装置、设备和存储介质
CN113707260A (zh) * 2021-08-30 2021-11-26 康键信息技术（深圳）有限公司 处方药品开立方法、装置、设备及存储介质

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103198409A (zh) * 2013-03-28 2013-07-10 福州天虹电脑科技有限公司 一种用于药品流通非现场监管方法
EP3214598A1 (fr) * 2014-10-31 2017-09-06 Masashi Kimura Dispositif de serveur de gestion d'informations médicales et procédé pour gérer des informations médicales
CN107330284A (zh) * 2017-07-06 2017-11-07 上海观谷科技有限公司 药品信息管理方法、装置和系统
CN107358449A (zh) * 2017-07-10 2017-11-17 安徽达仁信息科技有限公司 一种药品安全溯源系统及溯源方法
CN108172302A (zh) * 2017-12-15 2018-06-15 广州市康软信息科技有限公司 合理用药信息监测方法及系统
CN109616177A (zh) * 2018-12-13 2019-04-12 平安医疗健康管理股份有限公司 医疗机构的药品监控管理方法、装置、设备和存储介质

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101792790B (zh) * 2009-10-29 2013-08-14 中国兽医药品监察所 动物源细菌耐药性的分析方法及实现所述分析方法的系统
CN201698489U (zh) * 2010-07-09 2011-01-05 北京市药品监督管理局东城分局 一种医疗机构药品质量监管系统
CN102012974A (zh) * 2010-12-15 2011-04-13 中国人民解放军第四军医大学 临床安全合理用药决策支持系统
CN105224794A (zh) * 2015-09-19 2016-01-06 石庆平 一种智能化处方审核系统及方法
CN105809452A (zh) * 2016-03-01 2016-07-27 万达信息股份有限公司 药品供应链中药企到医疗机构的全面监控方法
CN106339598A (zh) * 2016-08-31 2017-01-18 杭州逸曜信息技术有限公司 利用警示信息的提示处理方法
CN107153765A (zh) * 2017-05-11 2017-09-12 杭州逸曜信息技术有限公司 抗菌药物的用药信息处理方法及装置
CN108511041B (zh) * 2018-04-03 2019-04-19 成都宇亨智能设备科技有限公司 医院的智能药房管理系统

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103198409A (zh) * 2013-03-28 2013-07-10 福州天虹电脑科技有限公司 一种用于药品流通非现场监管方法
EP3214598A1 (fr) * 2014-10-31 2017-09-06 Masashi Kimura Dispositif de serveur de gestion d'informations médicales et procédé pour gérer des informations médicales
CN107330284A (zh) * 2017-07-06 2017-11-07 上海观谷科技有限公司 药品信息管理方法、装置和系统
CN107358449A (zh) * 2017-07-10 2017-11-17 安徽达仁信息科技有限公司 一种药品安全溯源系统及溯源方法
CN108172302A (zh) * 2017-12-15 2018-06-15 广州市康软信息科技有限公司 合理用药信息监测方法及系统
CN109616177A (zh) * 2018-12-13 2019-04-12 平安医疗健康管理股份有限公司 医疗机构的药品监控管理方法、装置、设备和存储介质

Also Published As

Publication number Publication date
CN109616177A (zh) 2019-04-12

Similar Documents

Publication Publication Date Title
WO2020119116A1 (fr) Procédé, appareil et dispositif de vérification d'assurance médicale basés sur l'analyse de données et support de stockage
WO2020006852A1 (fr) Procédé, appareil et dispositif de traitement de vérification de remboursement de frais de déplacement en libre-service et support de stockage informatique
WO2020119385A1 (fr) Procédé, dispositif, équipement et support de surveillance de génération de prescription sur la base d'une analyse de données
WO2020119384A1 (fr) Procédé, appareil et dispositif de détection d'anomalie d'assurance médicale sur la base d'une analyse de mégadonnées, et support
WO2020078053A1 (fr) Procédé, appareil et dispositif de détection d'anomalies de données médicales et support d'informations
WO2018194379A1 (fr) Procédé d'approbation de l'utilisation d'une carte à l'aide d'un identificateur de jeton sur la base d'une chaîne de blocs et structure en arbre de merkle associée à celui-ci, et serveur l'utilisant
WO2020078058A1 (fr) Procédé et dispositif d'identification d'anomalies de données médicales, terminal et support de stockage
WO2020224250A1 (fr) Procédé, appareil et dispositif pour déclenchement de contrat intelligent, et support de stockage
WO2020108111A1 (fr) Procédé d'identification de comportement de fraude d'assurance médicale, appareil, dispositif et support de mémoire lisible
WO2020087981A1 (fr) Procédé et appareil de génération de modèle d'audit de contrôle de risque, dispositif, et support de stockage lisible
WO2020113959A1 (fr) Procédé, appareil et dispositif d'évaluation de niveau de dialyse d'institution médicale et support d'informations
WO2020119176A1 (fr) Procédé de vérification de données de remboursement, serveur d'identification et support de stockage
WO2020147385A1 (fr) Procédé et appareil d'entrée de données, terminal et support d'informations lisible par ordinateur
WO2020077837A1 (fr) Procédé, appareil et dispositif de comptabilité de données de service, et support de stockage lisible par ordinateur
WO2020119104A1 (fr) Procédé, dispositif et appareil de surveillance et de gestion de médicaments pour des institutions médicales et support d'informations
WO2019019245A1 (fr) Procédé et système d'achat de portefeuille de fonds, et support d'informations
WO2020226456A1 (fr) Procédé et dispositif pour fournir des informations médicales par l'intermédiaire d'informations de prescription
TW202029043A (zh) 基於區塊鏈的業務處理系統、方法、計算設備及儲存媒體
WO2020119115A1 (fr) Procédé, dispositif, appareil de vérification de données, et support de stockage
WO2020147384A1 (fr) Procédé, dispositif et appareil de transaction sécurisée à base de chaîne de blocs, et support de stockage
WO2020087704A1 (fr) Procédé, appareil et dispositif de gestion d'informations de crédit et support d'enregistrement
WO2014038775A1 (fr) Système de remboursement de taxe, procédé de fourniture d'un processus de remboursement de taxe et dispositif de consommateur pour un magasin affilié
WO2020119131A1 (fr) Procédé et dispositif d'identification d'anomalies de régime médicamenteux, terminal et support de stockage lisible
WO2019019350A1 (fr) Procédé, appareil et dispositif permettant de générer une page d'ouverture de compte, et support d'informations lisible par ordinateur
WO2020119401A1 (fr) Procédé de surveillance de la pratique illégale d'un médecin, serveur de surveillance et support d'informations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19894664

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19894664

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 18/10/2021)

122 Ep: pct application non-entry in european phase

Ref document number: 19894664

Country of ref document: EP

Kind code of ref document: A1